SOX9 is a transcription factor that serves as a master regulator of chondrocyte differentiation and skeletal development 1. It binds the 5'-ACAAAG-3' DNA motif to promote expression of cartilage matrix genes including COL2A1, COL9A1, and ACAN 2. SOX9 is absolutely required for precartilaginous condensation and works with SOX5/SOX6 during early chondrogenesis, while also directing hypertrophic maturation by suppressing osteoblast differentiation through reduced β-catenin signaling 3. Beyond skeletal development, SOX9 functions in other tissues: it promotes astrocyte differentiation from pluripotent stem cells 4, regulates alternative splicing in pancreatic beta cells to maintain insulin secretion 5, and maintains lung progenitor proliferation by amplifying WNT and RTK signaling 6. SOX9 exhibits context-dependent roles in cancer: it acts as a tumor suppressor in colorectal cancer by inhibiting epithelial-mesenchymal transition and SOX2 induction, with low SOX9 expression correlating with poor prognosis 7. Therapeutically, SOX9 gene delivery via rAAV vectors in alginate hydrogels promotes cartilage regeneration by increasing extracellular matrix deposition in osteoarthritic chondrocytes 8. Mutations in SOX9 cause campomelic dysplasia and sex reversal disorders, underscoring its critical developmental roles.